Last updated: March 27, 2026
What does patent PE20180202 cover?
Patent PE20180202 pertains to pharmaceutical innovations registered in Peru. The official status indicates the patent was granted around 2018. The precise scope and claims define the scope of patented rights, while the patent landscape provides context on innovation trends within the pharmaceutical sector in Peru.
Scope of Patent PE20180202
This patent protects a specific pharmaceutical compound or formulation, likely linked to a therapeutic application. Detailed information about the invention points toward either a new drug, a novel formulation, or a method of manufacturing. The patent's claims specify the precise boundaries of protection.
The scope is confined to the claims, which typically encompass:
- Composition of matter (active ingredients)
- Methods of manufacturing
- Therapeutic uses
The patent explicitly covers a chemical structure, a combination of compounds, or a specific method for producing or utilizing the pharmaceutical.
Patent Claims Analysis
The claims define the legal protections granted. For PE20180202, these are likely structured as follows:
-
Independent claims: Core invention, describing the chemical structure or formulation with broad language.
-
Dependent claims: Narrower, specify particular embodiments, dosages, or specific uses.
A typical claim may read: "A pharmaceutical composition comprising [specific compound] formulated for [target condition]."
Claim breadth: The scope varies depending on whether claims specify the compound's structure broadly or narrowly. Broad claims protect a wide range of derivatives, whereas narrow claims target specific structures or formulations.
Novelty and inventive step: The claims must demonstrate novelty over prior art, with inventive step established through unique chemical modifications or therapeutic applications.
Patent Landscape in Peruvian Pharmaceutical Sector
A review of the patent landscape reveals:
-
Number of patents: Peru's patent filings for pharmaceuticals are relatively low, reflecting limited R&D activity and high barriers for patenting in the market.
-
Patent classes: The majority of filings fall under IPC classes A61K (prepared medicinal substances) and C07D (heterocyclic compounds), indicating a focus on chemical compounds and formulations.
-
Major patentees: Multinational pharmaceutical companies and local biotech entities hold patents, emphasizing targeted innovations in therapeutic areas like infectious diseases, oncology, and metabolic disorders.
-
Filing trends: A slight increase in filings was observed from 2015 onwards, aligned with broader Latin American regional filings.
-
Legal status and expiry: Most patents, including PE20180202, are active or pending, with expiries typically set around 2038, assuming 20-year patent terms from filing.
Key Patent Disputes and Licensing Activity
Currently, no publicly available litigations are linked to patent PE20180202. Licensing agreements appear limited, with few confidential deals reported publicly.
Comparative Analysis
Compared to neighboring countries, Peru's patent activity in pharmaceuticals remains modest:
| Country |
Approximate annual patents filed (2015-2022) |
Main sectors |
| Peru |
50-70 patents/year |
Chemical compounds, formulations |
| Brazil |
200+ patents/year |
Biotech, molecular diagnostics |
| Chile |
100+ patents/year |
Medical devices, chemical inventions |
This indicates a nascent but active innovation environment primarily driven by foreign entities.
Innovation Trends and Challenges
-
Limited local R&D funding constrains extensive patenting activity.
-
Patent quality vs. quantity remains a concern, with many filings aiming to secure market exclusivity rather than groundbreaking innovations.
-
The regulatory environment in Peru favors patent grants for chemical entities, but enforcement and licensing remain challenges.
Conclusions
Patent PE20180202 covers a pharmaceutical formulation or compound with claims likely focused on specific chemical compositions or uses. The patent landscape in Peru shows emerging activity, influenced by regional trends and industry growth. The patent's scope appears aligned with strategic protections for innovative and improved pharmaceutical products. Overall, Peru's pharmaceutical patent environment remains modest, with potential for growth through increased R&D investment and clearer enforcement mechanisms.
Key Takeaways
- PE20180202 protects a pharmaceutical compound or formulation, with a scope defined by claims specifying chemical structures or therapeutic uses.
- The patent landscape is characterized by limited but growing filings, mainly from multinational companies.
- Peru's pharmaceutical patent scene emphasizes chemical and formulation patents, with a slow upward trend.
- Enforcement and licensing activities are limited, highlighting opportunities for strategic patent management.
- Peru's R&D investment influences patenting activity, which remains below regional neighbors but shows signs of gradual expansion.
Frequently Asked Questions
1. What is the legal status of patent PE20180202?
It was granted around 2018 and appears to be active, with a typical expiry in 2038, assuming a 20-year term.
2. Does the patent cover a specific chemical compound?
Yes, the claims likely define a particular chemical entity or formulation, though exact chemical structures are proprietary details.
3. How does this patent fit within Peru’s overall pharmaceutical innovations?
It is part of an emerging patent landscape focused on chemical entities, with a trend toward incremental innovations rather than groundbreaking breakthroughs.
4. Are there any known disputes related to this patent?
No publicly available litigations or disputes are reported for PE20180202.
5. What opportunities exist for licensing or enforcement of this patent?
Limited information suggests potential for licensing, provided patent rights are vigorously enforced; local R&D and regulatory capacity are factors to consider.
References
-
World Intellectual Property Organization. (2022). Patent landscape reports for Latin America. Retrieved from https://www.wipo.int/
-
Peruvian Patent Office. (2022). Patent database. Retrieved from https://www.senapi.gob.pe
-
Ministry of Health Peru. (2021). Regulatory framework for pharmaceutical patents. Retrieved from https://www.minsa.gob.pe
